Biliary cast syndrome in portal hypertensive biliopathy: direct cholangioscopic findings and endoscopic therapy with metal stent

Abbreviations

CT: computed tomography

HCV: Hepatitis C virus

EHPVO: extrahepatic portal venus obstruction

ERCP: endoscopic retrograde cholangiopancreatography

HCC: hepatocellular carcinoma.

A 61-year-old man with asthma, diabetes mellitus, cirrhosis secondary to chronic hepatitis C virus (HCV) infection, and hepatocellular carcinoma (HCC), was admitted to our hospital because of progressive abdominal pain and jaundice of 7 days duration. On clinical examination, the patient had abdominal distention, tenderness in the right upper quadrant, and jaundice. His hemoglobin was 8.7 mg/dL; hematocrit, 25 %; white blood cells, 1.7 × 10⁹/L; international normalized ratio (INR), 1.4; total bilirubin, 15 mg/dL; direct bilirubin, 7.6 mg/dL; indirect bilirubin, 7.4 mg/dL; and alkaline phosphatase, 65 IU/L. The remaining laboratory parameters were within reference ranges.

• References

• 1 Dhiman RK, Behera A, Chawla YK et al. Portal hypertensive biliopathy. Gut 2007; 56: 1001-1008
• 2 Gleeson FC, Czaja AJ, Baron TH. Successful endoscopic management of biliary cast syndrome in nonliver transplant patients. J Clin Gastroenterol 2008; 42: 752-755
• 3 Katsinelos P, Kountouras J, Chatzimavroudis G et al. Combined endoscopic and ursodeoxycholic acid treatment of biliary cast syndrome in a non-transplant patient. World J Gastroenterol 2008; 14: 5223-5225
• 4 Gor NV, Levy RM, Ahn J et al. Biliary cast syndrome following liver transplantation: predictive factors and clinical outcomes. Liver Transpl 2008; 14: 1466-1472
• 5 Srinivasaiah N, Reddy MS, Balupuri S et al. Biliary cast syndrome: literature review and a single centre experience in liver transplant recipients. Hepatobiliary Pancreat Dis Int 2008; 7: 300-303